Abstract
Since publication of the previous edition of this Handbook in 1970, much new information has been gathered about kininases, the enzymes that inactivate kinins. This chapter provides a survey and update of research on kininases and enzymes that convert longer kinin peptides to the nonapeptide, bradykinin.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ackerly, J. A, Tsai, B.-S, Peach, M.J.: Role of converting enzyme in the responses of rabbit atria, aortas, and adrenal zona glomerulosa to (des-Asp1)angiotensin I. Circ. Res. 41, 231–238 (1977)
Aiken, J.W, Vane, J.R.: The renin-angiotensin system: inhibition of converting enzyme in isolated tissues. Nature 228, 30–34 (1970)
Aiken, J.W, Vane, J.R.: Inhibition of converting enzyme of the renin-angiotensin system in kidneys and hindlegs of dogs. Circ. Res. 30, 263–273 (1972)
Alabaster, V.A, Bakhle, Y.S.: Converting enzyme and bradykininase in the lung. Circ. Res. 30/31, Suppl. II, 11–72–11–84 (1972a)
Alabaster, V. A, Bakhle, Y. S.: The inactivation of bradykinin in the pulmonary circulation of isolated lungs. Br. J. Pharmacol. 45, 299–310 (1972b)
Alabaster, V.A, Bakhle, Y.S.: The bradykininase activities of extracts of dog lung. Br. J. Pharmacol. 47, 799–807 (1973)
Angus, C.W, Lee, H.-J, Wilson, I.B.: Substrate specificity of hog plasma angiotensinconverting enzyme. Biochim. Biophys. Acta 309, 169–174 (1973)
Ashutosh, K, Keighley, J.F.H.: Diagnostic value of serum angiotensin converting enzyme activity in lung diseases. Thorax 31, 552–557 (1976)
Ayers, C. R, Vaughan, E.D, Yancey, M.R, Bing, K.T, Johnson, C.G, Morton, C.: Effect of 1-sarcosine-8-alanine angiotensin II and converting enzyme inhibitor on renin release in dog acute renovascular hypertension. Circ. Res. 34/35, Suppl. I, 1–27–1–33 (1974)
Back, N, Steger, R.: Kinin-destroying (kininase) activity of cultured rodent fibroblasts L-929. Proc. Soc. Exp. Biol. Med. 153, 175–179 (1976)
Bailie, M.D, Barbour, J.A.: Effect of inhibition of peptidase activity on distribution of intrarenal blood flow. Am. J. Physiol. 228, 850–853 (1975)
Bakhle, Y. S.: Conversion of angiotensin I to angiotensin II by cell-free extracts of dog lung. Nature 220, 919–921 (1968)
Bakhle, Y.S.: Inhibition of angiotensin I converting enzyme by venom peptides. Br. J. Pharmacol. 43, 252–254 (1971)
Bakhle, Y.S.: Converting enzyme in vitro measurement and properties. In: Handbook of Experimental Pharmacology. Page, I.H, Bumpus, F.M. (eds.), Vol. XXXVII pp. 41–80. Berlin, Heidelberg, New York: Springer 1974
Bakhle, Y.S.: Pulmonary metabolism of bradykinin analogues and the contribution of angiotensin converting enzyme to bradykinin inactivation in isolated lungs. Br. J. Pharmacol. 159, 123–128 (1977)
Bakhle, Y. S, Reynard, A. M.: Characteristics of the angiotensin I converting enzyme from dog lung. Nature New Biol. 229, 187–189 (1971)
Bakhle, Y.S, Vane, J.R.: Pharmacokinetic function of the pulmonary circulation. Physiological Rev. 54, 1007–1045 (1974)
Barrett, J.D, Sambhi, M.P.: Pulmonary activation and degradation of angiotensin I: a dual enzyme system. Res. Commun. Chem. Pathol. Pharmacol. 2, 128–145 (1971)
Bedrossian, C.W.M, Woo, J, Miller, W.C, Cannon, D.C: Decreased angiotensin-converting enzyme in the adult respiratory distress syndrome. Am. J. Clin. Pathol. 70, 244–247 (1978)
Bengis, R.G, Coleman, T.G, Young, D.B, McCaa, R.E.: Long-term blockade of angiotensin formation in various normotensive and hypertensive rat models using converting enzyme inhibitor (SQ 14225). Circ. Res. 43, Suppl. I, I45–I53 (1978)
Benuck, M, Marks, N.: Subcellular localization and partial purification of a chloride dependent angiotensin-I converting enzyme from rat brain. J. Neurochem. 30, 729–734 (1978)
Bianchi, A, Evans, D.B, Cobb, M, Peschka, M.T, Schaeffer, T.R, Laffan, R.J.: Inhibition by SQ 20881 of vasopressor response to angiotensin I in conscious animals. Eur. J. Pharmacol. 23, 90–96 (1973)
Bielawiec, M, Bogdanikowa, B, Kiersnowska-Rogowska, B, Lukjan, H.: Studies on the kininogenic system in the supernatant of leukocyte cultures. Arch. Immunol. Ther. Exp. 22, 369–373 (1974)
Bing, J, Poulsen, K, Markussen, J.: The ability of various insulins and insulin fragments to inhibit the angiotensin I converting enzyme. Acta Pathol. Microbiol. Scand. [A] 82, 777–782 (1974)
Biron, P, Campeau, L, David, P.: Fate of angiotensin I and II in the human pulmonary circulation. Am. J. Cardiol. 24, 544–547 (1969)
Biron, P, Campeau, L.: Pulmonary and extrapulmonary fate of angiotensin I. Rev. Can. Biol. 30, 27–34 (1971)
Biron, P, Huggins, C.G.: Pulmonary activation of synthetic angiotensin I. Life Sci. 7, 965–970 (1968)
Blair-West, J.R, Coghlan, J.P, Denton, D.A, Funder, J.W, Scoggins, B.A, Wright, R.D.: The effect of the heptapeptide (2–8) and hexapeptide (3–8) fragments of angiotensin II on aldosterone secretion. J. Clin. Endocrinol. Metab. 32, 575–578 (1971)
Boaz, D, Wyatt, S, Fitz, A.: Angiotensin I (Phe8-His9) hydrolase — studies with renin substrates. Biochem. Biophys. Res. Commun. 63, 490–495 (1975)
Bokisch, V.A, Muller-Eberhard, H.J, Cochrane, C.G.: Isolation of a fragment (C3a) of the third component of human complement containing anaphylatoxin and chemotactic activity and description of an anaphylatoxin inactivator of human serum. J. Exp. Med. 129, 1109–1130 (1969)
Bokisch, V.A, Muller-Eberhard, H.J.: Anaphylatoxin inactivator of human plasma: its isolation and characterization as a carboxypeptidase. J. Clin. Invest. 49, 2427–2436 (1970)
Borges, D.R, Prado, J.L, Guimaraes, J.A.: Characterization of a kinin-converting arylaminopeptidase from human liver. N.S. Arch. Pharmacol. 281, 403–414 (1974)
Borges, D.R, Limaos, E.A, Prado, J.L, Camargo, A.CM.: Catabolism of vasoactive polypeptides by perfused rat liver. N.S. Arch. Pharmacol. 295, 33–40 (1976)
Boucher, R, Asselin, J, Genest, J.: A new enzyme leading to the direct formation of angiotensin II. Circ. Res. 34/35, Suppl. I, I–203–I–209 (1974)
Brandi, C.M., Prado, E.S, Prado, M.J.B.A, Prado, J.L.: Kinin-converting aminopeptidase from human urine partial purification and properties. Int. J. Biochem. 7, 335–341 (1976)
Brantner, H.: Enzymuntersuchungen an einem onkolytisch wirkenden Clostridium-Stamm (CI. butyricum-Stamm M55). Zentralbl. Bakteriol. [Orig. A] 220, 432–434 (1972)
Brecher, P.I, Tercyak, A, Gavras, H, Chobanian, A.V.: Angiotensin-converting enzyme activity in cerebral micro vessels. Fed. Proc. 37, 603 (1978)
Britton, S, Di Salvo, J.: Effects of angiotensin I and angiotensin II on hindlimb and coronary vascular resistance. Am. J. Physiol. 225, 1226–1231 (1973)
Caldwell, P.R.B, Seegal, B.C., Hsu, K.C, Das, M, Soffer, R.L.: Angiotensin-converting enzyme: vascular endothelial localization. Science 191, 1050–1051 (1976a)
Caldwell, P.R.B, Wigger, H.J, Das, M, Soffer, R.L.: Angiotensin-converting enzyme: effect of antienzyme antibody in vivo. FEBS Letters 63, 82–84 (1976b)
Camargo, A.C.M., Graeff, F.G.: Subcellular distribution and properties of the bradykinin inactivation system in rabbit brain homogenates. Biochem. Pharmacol. 18, 548–549 (1969)
Camargo, A.C.M., Ramalho-Pinto, F.J, Greene, L.J.: Brain peptidases: conversion and inactivation of kinin hormones. J. Neurochem. 19, 37–49 (1972)
Camargo, A.C.M., Shapanka, R, Greene, L.J.: Preparation, assay, and partial characterization of a neutral endopeptidase from rabbit brain. Biochemistry 12, 1838–1844 (1973)
Carmel, A, Yaron, A.: An intramolecularly quenched fluorescent tripeptide as a fluorogenic substrate of angiotensin-I-converting enzyme and of bacterial dipeptidyl carboxypeptidase. Eur. J. Biochem. 87, 265–273 (1978)
Carone, F.A, Pullman, T.N, Oparil, S, Nakamura, S.: Micropuncture evidence of rapid hydrolysis of bradykinin by rat proximal tubule. Am. J. Physiol. 230, 1420–1424 (1976)
Carriere, S, Biron, P.: Effect of angiotensin I on intrarenal blood flow distribution. Am. J. Physiol. 219, 1642–1646 (1970)
Case, D.B, Wallace, J.M, Keim, H.J, Weber, M. A, Drayer, J.I.M, White, R.P, Sealey, J.E, Laragh, J.H.: Estimating renin participation in hypertension: superiority of converting enzyme inhibitor over saralasin. Am. J. Med. 61, 790–796 (1976)
Case, D.B, Wallace, J.M, Keim, H.J, Weber, M. A, Sealey, J.E, Laragh, J.H.: Possible role of renin in hypertension as suggested by renin-sodium profiling and inhibition of converting enzyme. N. Engl. J. Med. 296, 641–646 (1977)
Cheung, H.S, Cushman, D.W.: Inhibition of homogeneous angiotensin-converting enzyme of rabbit lung by synthetic venom peptides of Bothrops jararaca. Biochim. Biophys. Acta 293, 451–463 (1973)
Chiu, A.T, Ryan, J.W, Stewart, J.M, Dorer, F.E.: Formation of angiotensin III by angiotensin-converting enzyme. Biochem. J. 155, 189–192 (1976)
Cicilini, M.A, Caldo, H, Berti, J.D, Camargo, A.CM.: Rabbit tissue peptidases that hydrolyse the peptide hormone bradykinin. Biochem. J. 163, 433–439 (1977)
Collier, J.G, Robinson, B.F, Vane, J.R.: Reduction of pressor effects of angiotensin I in man by synthetic nonapeptide (B.P.P.9α or SQ 20,881) which inhibits converting enzyme. Lancet 1, 72–74 (1973)
Collier, J.G, Robinson, B.F.: Comparison of effects of locally infused angiotensin I and II on hand veins and forearm arteries in man: evidence for converting enzyme activity in limb vessels. Clin. Sci. Mol. Med. 47, 189–192 (1974)
Conroy, J.M, Hartley, J.L, Soffer, R.L.: Canine pulmonary angiotensin-converting enzyme physicochemical, catalytic and immunological properties. Biochim. Biophys. Acta 524, 403–412 (1978)
Conroy, J.M, Hoffman, H, Kirk, E. S, Hirzel, H.O, Sonnenblick, E.H, Soffer, R.L.: Pulmonary angiotensin-converting enzyme. Interspecies homology and inhibition by heterologous antibody in vivo. J. Biol. Chem. 251, 4828–4832 (1976)
Conroy, J.M, Lai, C.Y.: A rapid and sensitive fluorescence assay for angiotensin-converting enzyme. Anal. Biochem. 87, 556–561 (1978)
Corbin, N.C, Hugli, T.E, Muller-Eberhard, H.J.: Serum carboxypeptidase B: a spectrophotometric assay using protamine as substrate. Anal. Biochem. 73, 41–51 (1976)
Cushman, D.W, Cheung, H.S.: A simple substrate for assay of dog lung angiotensin converting enzyme. Fed. Proc. 28, 799 (1969)
Cushman, D.W, Cheung, H.S.: Concentrations of angiotensin-converting enzyme in tissues of the rat. Biochim. Biophys. Acta 250, 261–265 (1971a)
Cushman, D.W, Cheung, H.S.: Spectrophotometric assay and properties of the angiotensinconverting enzyme of rabbit lung. Biochem. Pharmacol. 20, 1637–1648 (1971b)
Cushman, D.W, Cheung, H.S.: Studies in vitro of angiotensin-converting enzyme of lung and other tissues. In: Hypertension’ 72. Genest, J, Koiw, E. (eds.), pp. 532–541. Berlin, Heidelberg, New York: Springer 1972
Cushman, D.W, Pluscec, J, Williams, N.J, Weaver, E.R, Sabo, E.F, Kocy, O, Cheung, H.S, Ondetti, M. A.: Inhibition of angiotensin-converting enzyme by analogs of peptides from Bothrops jararaca venom. Experientia 29, 1032–1035 (1973)
Cushman, D.W, Cheung, H.S, Sabo, E.F, Ondetti, M.A.: Design of potent competitive inhibitors of angiotensin-converting enzyme. Carboxyalkanoyl and mercaptoalkanoyl amino acids. Biochemistry 16, 5484–5491 (1977)
Damas, J.: L’activite kininasique du liquide cephalo-rachidien de l–Homme, in vitro. C.R. Soc. Biol. 163, 2478–2483 (1969)
Das, M, Hartley, J.L, Soffer, R.L.: Serum angiotensin-converting enzyme. Isolation and relationship to the pulmonary enzyme. J. Biol. Chem. 252, 1316–1319 (1977)
Das, M, Soffer, R.L.: Pulmonary angiotensin-converting enzyme. Structural and catalytic properties. J. Biol. Chem. 250, 6762–6768 (1975)
Das, M, Soffer, R.L.: Pulmonary angiotensin-converting enzyme antienzyme antibody. Biochemistry 15, 5088–5094 (1976)
Dearnley, C.N, Bailey, G.S.: Subcellular distribution of kininase activity in pig liver. Biochem. Soc. Transact. 4, 697–698 (1976)
Dedichen, J, Vystyd, J.: Kininase activity of plasma from patients with arteriosclerosis, diabetes and hepatitis. Scand. J. Clin. Lab. Invest. 107, 125–127 (1969)
Delhaye, C, Reuse, J.J, Driessche, R.V.: Presence du systeme bradykininogene — bradykinine — bradykininase dans le liquide amniotique humain. Arch. Int. Pharmacodyn. Ther. 179, 486–489 (1969)
Depierre, D, Bargetzi, J.-P, Roth, M.: Dipeptidyl carboxypeptidase from human seminal plasma. Biochim. Biophys. Acta. 523, 469–476 (1978)
Depierre, D, Roth, M.: Activity of a dipeptidyl carboxypeptidase (Angiotensin converting enzyme) in lungs of different animal species. Experientia 28, 154 (1972)
Depierre, D, Roth, M.: Fluorimetric determination of dipeptidyl carboxypeptidase (angiotensin-I-converting enzyme). Enzyme 19, 65–70 (1975)
Disalvo, J, Britton, S, Galvas, P, Sanders, T.W.: Effects of angiotensin I and angiotensin II on canine hepatic vascular resistance. Circ. Res. 32, 85–92 (1973)
Disalvo, J, Peterson, A, Montefusco, C, Menta, M.: Intrarenal conversion of angiotensin I to angiotensin II in the dog. Circ. Res. 29, 398–406 (1971)
Donaldson, V. H.: Bradykinin inactivation by rabbit serum and butylated hydroxyanisole. J. Appl. Physiol. 35, 880–883 (1973)
Dorer, F.E, Skeggs, L.T, Kahn, J.R, Lentz, K.E, Levine, M.: Angiotensin converting enzyme: Method of assay and partial purification. Anal. Biochem. 33, 102–113 (1970)
Dorer, F.E, Kahn, J.R, Lentz, K.E, Levine, M, Skeggs, L.T.: Purification and properties of angiotensin-converting enzyme from hog lung. Circ. Res. 31, 356–366 (1972)
Dorer, F.E, Kahn, J.R, Lentz, K.E, Levine, M, Skeggs, L.T.: Hydrolysis of bradykinin by angiotensin-converting enzyme. Circ. Res. 34, 824–827 (1974a)
Dorer, F.E, Kahn, J.R, Lentz, K.E, Levine, M, Skeggs, L.T.: Formation of angiotensin II from tetradecapeptide renin substrate by angiotensin-converting enzyme. Biochem. Pharmacol. 24, 1137–1139 (1975)
Dorer, F.E, Kahn, J.R, Lentz, K.E, Levine, M, Skeggs, L.T.: Kinetic properties of pulmonary angiotensin-converting enzyme. Hydrolysis of hippurylglycylglycine. Biochim. Biophys. Acta 429, 220–228 (1976)
Dorer, F.E, Ryan, J.W, Stewart, J.M.: Hydrolysis of bradykinin and its higher homologues by angiotensin-converting enzyme. Biochem. J. 141, 915–917 (1974b)
Druilhet, R.E, Overturf, M, Kirkendall, W.M.: Action of a human plasma fraction on tetradecapeptide, angiotensin I and angiotensin II. Life Sci. 20, 1213–1226 (1977)
Edery, H.: Sensitization of smooth muscle to the action of plasma kinins by chymotrypsin. In: Hypotensive peptides. Erdös, E.G., Back, N, Sicuteri, F. (eds.), pp.341–343. New York: Springer 1966
Elisseeva, Y.E, Orekhovich, V. N, Pavlikhina, L.V, Alexeenko, L.P.: Carboxycathepsin-A key regulatory component of two physiological systems involved in regulation of blood pressure. Clin. Chim. Acta 31, 413–419 (1971)
Elisseeva, J.J, Orekhovich, V.N, Pavlikhina, L.V.: Properties and specificity of carboxycathepsin (peptidyl-dipeptidase) from bovine kidney. Voprosy Med. Khimii. 22, 81–89 (1974a)
Elisseeva, Y.E, Orekhovich, V.N, Pavlikhina, L.V.: Isolation and properties of carboxycathepsin (peptidyl-dipeptidase) from bovine lung tissue. Biochemistry (Trans, of Biokhimiya) 41, 417–122 (1976)
Elisseeva, Y.E, Pavlikhina, L.V, Orekhovich, V.N.: Isolation of carboxycathepsin (peptidyl dipeptidase 3.4.15.1) from beef kidneys. Doklady Akademii Nauk SSSR 217, 953–956 (1974b)
Engel, S.L, Schaeffer, T.R, Gold, B.I, Rubin, B.: Inhibition of pressor effects of angiotensin I and augmentation of depressor effects of bradykinin by synthetic peptides. Proc. Soc. Exp. Biol. Med. 140, 240–244 (1972)
Engel, S.L, Schaeffer, T.R, Waugh, M.H, Rubin, B.: Effects of the nonapeptide SQ 20881 on blood pressure of rats with experimental renovascular hypertension. Proc. Soc. Exp. Biol. Med. 143, 483–487 (1973)
Epstein, A.N, Simpson, J.B.: The dipsogenic action of angiotensin. Acta Physiol. Lat. Am. 24, 405–409 (1974)
Erdös, E.G.: Enzymes that inactivate polypeptides. In: Metabolic Factors Controlling Duration of Drug Action. Brodie, B.B, Erdös, E.G. (eds.), pp. 159–178. New York: Pergamon Press 1962
Erdös, E.G.: Urinary kinin and colostrokinin. In: Handbook of Experimental Pharmacology. Erdös, E.G. (ed.), Vol. XXV, pp.579–584. Berlin, Heidelberg, New York: Springer 1970
Erdös, E.G.: Angiotensin I converting enzyme. (Brief review.) Circ. Res. 36, 247–255 (1975)
Erdös, E.G.: The kinins — A status report. Biochem. Pharmacol. 25, 1563–1569 (1976a)
Erdös, E.G.: Conversion of angiotensin I to angiotensin II. Am. J. Med. 60, 749–759 (1976b)
Erdös, E.G.: The angiotensin I converting enzyme. Fed. Proc. 36, 1760–1768 (1977)
Erdös, E.G., Johnson, A.R, Boyden, N.T.: Inactivation of enkephalins: effect of purified peptidyl dipeptidase and cultured human endothelial cells. “Endorphins”. In: Advances in biochemical psychopharmacology. Costa, E, Trabucchi, M. (eds.), Vol. 18, pp. 45–49. New York: Raven Press 1978a
Erdös, E.G., Johnson, A.R, Boyden, N.T.: Hydrolysis of enkephalin by cultured human endothelial cells and by purified peptidyl dipeptidase. Biochem. Pharm. 27, 843–848 (1978b)
Erdös, E.G., Johnson, A.R, Robinson, C.J.G.: Release of angiotensin I converting enzyme from the shocked rat lung. Circulation 52,11–88 (1975)
Erdös, E.G., Marinkovic, D.M, Ward, P.E, Mills, I.H.: Characterization of urinary kininase. Fed. Proc. 31, 657 (1978c)
Erdös, E.G., Massion, W.H, Downs, D.R, Geese, A.: Effect of angiotensin I converting enzyme inhibitor in shock. Proc. Soc. Exp. Biol. Med. 145, 948–951 (1974)
Erdös, E.G., Nakajima, T, Oshima, G, Geese, A, Kato, J.: Kininases and their interaction with other systems. In: Chemistry and Biology of the Kallikrein-kinin System in Health and Disease. Pisano, J.F, Austen, K.F. (eds.). DHEW Publication No. NIH 76-791, pp. 277–285 (1976)
Erdös, E.G., Renfrew, A. G, Sloane, E. M, Wohler, J. R.: Enzymatic studies on bradykinin and similar peptides. Ann. N.Y. Acad. Sci. 104, 222–234 (1963)
Erdös, E.G., Sloane, E. M.: An enzyme in human blood plasma that inactivates bradykinin and kallidins. Biochem. Pharmacol. 11, 585–592 (1962)
Erdös, E.G., Wohler, I.M, Levine, M.I, Westerman, M.P.: Carboxypeptidase in blood and other fluids. Values in human blood in normal and pathological conditions. Clin. Chim. Acta. 11, 39–43 (1965)
Erdös, E.G., Yang, H.Y.T.: Inactivation and potentiation of the effects of bradykinin. In: Hypotensive peptides. Erdös, E.G., Back, B, Sicuteri, F. (eds.), pp.235–250. Berlin, Heidelberg, New York: Springer 1966
Erdös, E.G., Yang, H.Y.T.: An enzyme in microsomal fraction of kidney that inactivates bradykinin. Life Sci. 6, 569–574 (1967)
Erdös, E.G., Yang, H.Y.T, Tague, L.L, Manning, N.: Carboxypeptidase in blood and other fluids. III. The esterase activity of the enzyme. Biochem. Pharmacol. 16, 1287–1297 (1967)
Erdös, E.G., Yang, H.Y.T.: Kininases. In: Handbook of Experimental Pharmacology. Erdös, E.G. (ed.), Vol. XXV, pp.289–323. Berlin, Heidelberg, New York: Springer 1970
Errington, M.L, RochaeSilva, M.: On the role of vasopressin and angiotensin in the development of irreversible haemorrhagic shock. J. Physiol. 242, 119–141 (1974)
Fanburg, B.L, Schoenberger, M.D, Bachus, B, Snider, G.L.: Elevated serum angiotensin I converting enzyme in sarcoidosis. Am. Rev. Resp. Dis. 114, 525–528 (1976)
Ferguson, R.K, Brunner, H.R, Turini, G.A, Gavras, H, McKinstry, D.N.: A specific orally active inhibitor of angiotensin-converting enzyme in man. Lancet 1, 775–778 (1977)
Fernandez, H.N, Hugli, T.E.: Partial characterization of human C5a anaphylatoxin. I. Chemical description of the carbohydrate and polypeptide portions of human C5a. J. Immunol. 117, 1688–1694 (1976)
Ferreira, S.H.: A bradykinin-potentiating factor (BPF) present in the venom of Bothrops jararaca. Br. J. Pharmacol. 24, 163–169 (1965)
Ferreira, S.H.: Bradykinin-potentiating factor. In: Hypotensive Peptides. Erdös, E.G., Back, N, Sicuteri, F. (eds.), pp.356–367. New York: Springer 1966
Ferreira, S.H, Bartelt, D.C, Greene, L.J.: Isolation of bradykinin-potentiating peptides from Bothrops jararaca venom. Biochemistry 9, 2583–2593 (1970)
Ferreira, S.H, Vane, J.R.: The disappearance of bradykinin and eledoisin in the circulation and vascular beds of the cat. Br. J. Pharmacol. Chemother. 30, 417–424 (1967)
Filipovic, N, Mijanovic, M, Igic, R.: A simple spectrophotometric method for estimation of plasma angiotensin I converting enzyme activity. Clin. Chim. Acta 88, 173–175 (1978)
Fitz, A, Overturf, M.: Molecular weight of human angiotensin I lung converting enzyme. J. Biol. Chem. 247, 581–584 (1972)
Fitz, A, Wyatt, S, Boaz, D, Fox, B.: Peptide inhibitors of converting enzyme. Life Sci. 21, 1179–1186 (1977)
Folk, J.E, Piez, K. A, Carroll, W.R, Gladner, J. A.: Carboxypeptidase B. IV. Purification and characterization of the porcine enzyme. J. Biol. Chem. 235, 2272–2277 (1960)
Franklin, W.G, Peach, M.J, Gilmore, J.P.: Evidence for the renal conversion of angiotensin I in the dog. Circ. Res. 27, 321–324 (1970)
Freer, R.J, Stewart, J.M.: In vivo pulmonary metabolism of bradykinin, angiotensin I and 5-hydroxytryptamine in the rat. Arch. Int. Pharmacodyn. Ther. 217, 97–109 (1975)
Frey, E.K, Kraut, H, Werle, E, Vogel, R, Zickgraf-Rudel, G, Trautschold, I.: Das Kallikrein-Kinin-System und seine Inhibitoren. Stuttgart: Enke 1968
Friedland, J, Silverstein, E.: Similarity in some properties of serum angiotensin converting enzyme from sarcoidosis patients and normal subjects. Biochem. Med. 15, 178–185 (1976)
Friedland, J, Silverstein, E.: Sensitive fluorimetric assay for serum angiotensin-converting enzyme with the natural substrate angiotensin I. Am. J. Clin. Pathol. 68, 225–228 (1977)
Friedland, J, Setton, C, Silverstein, E.: Angiotension converting enzyme: induction by steroids in rabbit alveolar macrophages in culture. Science 197, 64–65 (1977)
Friedland, J, Silverstein, E.: Angiotensin converting enzyme (ACE): apparent identity of rabbit macrophage and lung enzymes and proteolytic processing of predominant large cellular to small extracellular form. Fed. Proc. 37, 1332 (1978)
Friedland, J, Setton, C, Silverstein, E.: Induction of angiotensin converting enzyme in human monocytes in culture. Biochem. Biophys. Res. Commun. 83, 843–849 (1978)
Friedli, B, Biron, P, Fouron, J.-C, Davignon, A.: Conversion of angiotensin I in pulmonary and systemic vascular beds of children. Acta Paediatr. Scand. 63, 17–22 (1974)
Friedli, B, Kent, G, Olley, P. M.: Inactivation of bradykinin in the pulmonary vascular bed of newborn and fetal lambs. Circ. Res. 33, 421–427 (1973)
Fujita, K, Teradaira, R, Nagatsu, T.: Bradykininase activity of aloe extract. Biochem. Pharmacol. 25, 205 (1975)
Gaponiuk, P. YA, Umarchodgaev, E. M.: The changes of plasma kininase activity in irradiated animals. Stud. Biophys. 13, 225–230 (1969)
Gavras, H, Brunner, H.R, Laragh, J.H, Sealey, J.E, Gavras, I, Vukovich, R.A.: An angiotensin converting-enzyme inhibitor to identify and treat vasoconstrictor and volume factors in hypertensive patients. N. Engl. J. Med. 291, 817–821 (1974)
Gavras, H, Brunner, H.R, Turini, G.A., Kershaw, G.R, Tifft, C P, Cuttelod, S, Gavras, I, Vukovich, R.A, McKinstry, D.N.: Antihypertensive effect of the oral angiotensin converting-enzyme inhibitor SQ 14225 in man. N. Engl. J. Med. 298, 991–995 (1978a)
Gavras, H, Gavras, I, Textor, S, Volicer, L, Brunner, H.R, Rucinska, E.J.: Effect of angiotensin converting enzyme inhibition on blood pressure, plasma renin activity and plasma aldosterone in essential hypertension. J. Clin. Endocrinol. Metabol. 46, 220–226 (1978b)
Gavras, H, Liang, C-S, Brunner, H. R.: Redistribution of regional blood flow after inhibition of the angiotensin-converting enzyme. Circ. Res. 43, Supp. I, 1–59-1-63 (1978c)
Geese, A, Lonovics, J, Zsilinszky, E, Szekeres, L.: Characteristics of the human skin bradykinin-destroying enzyme. J. Med. 2, 129–135 (1971)
Geokas, M. C, Wollesen, F, Rinderknecht, H.: Radioimmunoassay for pancreatic carboxypeptidase B in human serum. J. Lab. Clin. Med. 84, 574–583 (1974)
Gladner, J. A.: Potentiation of the effect of bradykinin. In: Hypotensive peptides. Erdös, E.G., Back, N, Sicuteri, F. (eds.), pp.344–355. New York: Springer 1966
Grandino, A, Paiva, A.CM.: Isolation of angiotensin-converting enzyme without kininase activity from hog and guinea pig plasma. Biochim. Biophys. Acta 364, 113–119 (1974)
Greene, L.J, Camargo, A.C.M., Krieger, E.M, Stewart, J.M, Ferreira, S.H.: Inhibition of the conversion of angiotensin I to II and potentiation of bradykinin by small peptides present in Bothrops jararaca venom. Circ. Res. 30/31, Suppl. II, II–62–II–71 (1972)
Guimaraes, J.A, Borges, D.R, Prado, E.S, Prado, J.L.: Kinin-converting aminopeptidase from human serum. Biochem. Pharmacol. 22, 3157–3172 (1973)
Hall, E.R, Kato, J, Erdös, E.G., Robinson, C.J.G, Oshima, G.: Angiotensin I-converting enzyme in the nephron. Life Sci. 18, 1299–1303 (1976)
Hamberg, U, Elg, P, Stelwagen, P.: On the mechanism of bradykinin potentiation. In: Advances in Experimental Medicine and Biology. Back, N, Martini, L, Paoletti, R. (eds.), Plenum Press New York, Vol. 2, pp. 626–631, 1968
Hayakari, M, Kondo, Y.: A rapid fluorometric assay of angiotensin-converting enzyme. Tohoku J. Exp. Med. 122, 313–320 (1977)
Hayakari, M, Kondo, Y, Izumi, H.: A rapid and simple spectrophotometric assay of angiotensin-converting enzyme. Anal. Biochem. 84, 361–369 (1978)
Hebert, F, Fouron, J.C, Boileau, J.C, Biron, P.: Pulmonary fate of vasoactive peptides in fetal, newborn, and adult sheep. Am. J. Physiol. 223, 20–23 (1972)
Helmer, O. M.: Differentiation between two forms of angiotensin by means of spirally cut strips of rabbit aorta. Am. J. Physiol. 188, 571–577 (1957)
Herman, C. M, Oshima, G, Erdös, E. G.: The effect of adrenocorticosteroid pretreatment on the kinin system and coagulation responses to septic shock in the baboon. J. Lab. Clin. Med. 84, 731–739 (1974)
Hial, V, Gimbrone, Jr., M. A, Wilcox, G, Pisano, J.J.: Human vascular endothelium contains angiotensin I converting enzyme and renin-like activity. Fed. Proc. 35, 705 (1976)
Hirsch, E.F, Nakajima, T, Oshima, G, Erdös, E.G., Herman, C.M.: Kinin system responses in sepsis following trauma in man. J. Surg. Res. 17, 147–153 (1974)
Hofbauer, K.G, Zschiedrich, H, Rauh, W, Gross, F.: Conversion of angiotensin I into angiotensin II in the isolated perfused rat kidney. Clin. Sci. 44, 447–456 (1973a)
Hofbauer, K.G, Zschiedrich, H, Rauh, W, Orth, H, Gross, F.: Reaction of endogenous renin with exogenous renin substrate within the isolated perfused rat kidney. Proc. Soc. Exp. Biol. Med. 142, 796–799 (1973b)
Hojima, Y, Moriya, H, Moriwaki, C: Bradykinin inactivating enzymes from red kidney beans (Phaseolus vulgaris) and potatoes (Solanum tÜberosum). Agric. Biol. Chem. 41, 559–565 (1977)
Hojima, Y, Tanaka, M, Moriya, H, Moriwaki, C.: Kinin-inactivating-enzymes from plants I. Partial purification of bradykinin-inactivating-enzyme from potatoes. Allergy 20, 755–762 (1971a)
Hojima, Y, Tanaka, M, Moriya, H, Moriwaki, C.: Kinin-inactivating-enzymes from plants II. Some properties of bradykinin-inactivating-enzyme from potatoes. Allergy 20, 763–769 (1971b)
Hopsu, V.K, Mäkinen, K.K, Glenner, G.G.: A peptidase (aminopeptidase B) from cat and guinea pig liver selective for N-terminal arginine and lysine residues. I. Purification and substrate specificity. Acta Chem. Scand. 20, 1225–1230 (1966a)
Hopsu, V. K, Mäkinen, K. K, Glenner, G. G.: A peptidase (aminopeptidase B) from cat and guinea pig liver selective for N-terminal arginine and lysine residues. II. Modifier characteristics and kinetic studies. Acta Chem. Scand. 20, 1231–1239 (1966b)
Horky, K, Rojo-Ortega, J.M, Rodriguez, J, Boucher, R, Genest, J.: Renin, renin substrate, and angiotensin I-converting enzyme in the lymph of rats. Am. J. Physiol. 220, 307–311 (1971)
Huggins, C.G, Corcoran, R.J, Gordon, J.S, Henry, H.W, John, J.P.: Kinetics of the plasma and lung angiotensin I converting enzymes. Circ. Res. 26/27, Suppl. 1,1–93-1-108 (1970)
Huggins, C.G, Thampi, N.S.: A simple method for the determination of angiotensin I converting enzyme. Life Sci. 7, 633–639 (1968)
Hugli, T.E, Vallota, E.H, Muller-Eberhard, H.J.: Purification and partial characterization of human and porcine C3a anaphylatoxin. J. Biol. Chem. 250, 1472–1478 (1975)
Igic, R, Erdös, E.G., Yeh, H.S.J, Sorrells, K, Nakajima, T.: The angiotensin I converting enzyme of the lung. Circ. Res. 31,11–51-11-61 (1972a)
Igic, R, Nakajima, T, Yeh, H.S.J, Sorrells, K, Erdös, E.G.: Kininases. In: Pharmacology and the future of man. Acheson, G.H. (ed.), Vol.5, pp. 307–319. Basel: Karger 1973
Igic, R, Robinson, C.J.G, Erdös, E.G.: Antiotensin I converting enzyme activity in the choroid plexus and in the retina. In: Central actions of angiotensin and related hormones. Buckley, J.P, Ferrario, C.M. (eds.), pp.23–27. New York: Pergamon Press 1977
Igic, R, Sorrells, K, Yeh, H.S.J, Erdös, E.G.: Identity of kininase II with an angiotensin I converting enzyme. In: Vasopeptides: Chemistry, pharmacology and pathophysiology. Back, N, Sicuteri, F. (eds.), pp. 149–153. New York: Plenum Press 1972b
Igic, R, Yeh, H.S.J, Sorrells, K, Erdös, E.G.: Cleavage of active peptides by a lung enzyme. Experientia 28, 135–136 (1972c)
Iwata, H, Shimiki, T, Oka, T.: Pharmacological significances of peptidase and proteinase in the brain (Report l)-enzymatic inactivation of bradykinin in rat brain. Biochem. Pharmacol. 18, 119–128 (1969)
Iwata, H, Shikimi, T, Iida, M, Müchi, H.: Pharmacological significances of peptidase and proteinase in the brain. Report 4: effect of bradykinin on the central nervous system and role of the enzyme inactivating bradykinin in mouse brain. Jpn. J. Pharmacol. 20, 80–86 (1970)
Jaeger, P, Ferguson, R.K, Brunner, H.R, Kirchertz, E.J, Gavras, H.: Mechanism of blood pressure reduction by teprotide (SQ 20881) in rats. Kidney Int. 13, 289–296 (1978)
Jakschik, B.A, McKnight, R.C, Marshall, G.R, Feldhaus, R.A, Needleman, P.: Renal vascular changes during hemorrhagic shock and the pharmacologic modification by angiotensin and catecholamine antagonists. Circ. Shock. 1, 231–237 (1974)
Jeanneret, L, Roth, M, Bargetzi, J.-P.: Carboxypeptidase N from pig serum. H.-S. Z. Physiol. Chem. 357, 867–872 (1976)
Johnson, A.R, Boyden, N.T.: Proteases in cultured human endothelial cells. In: Kininogenases, kallikrein. Haberland, G.L, Rohen, J.W, Suzuki, T. (eds.), pp. 113–118. Stuttgart, New York: Schattauer 1977
Johnson, A.R, Boyden, N.T, Wilson, C.M.: The growth-promoting actions of extracts from mouse submaxillary glands on human endothelial cells in culture. Submitted (1979)
Johnson, A.R, Erdös, E.G.: Angiotensin I converting enzyme in human endothelial cells. Circulation 52, 11–59 (1975)
Johnson, A.R, Erdös, E.G.: Metabolism of vasoactive peptides by human endothelial cells in culture: angiotensin I converting enzyme (kininase II) and angiotensinase. J. Clin. Invest. 59, 684–695 (1977)
Johnson, A.R, Erdös, E.G.: Activities of enzymes in human pulmonary endothelial cells in culture. Circulation 58, 11–108 (1978)
Kangasniemi, P, Riekkinen, P, Penttinen, R, Ivaska, K, Rinne, U. K.: Enzyme changes in the cerebrospinal fluid and serum and their correlation to the breakdown of bradykinin during different stages of headache attacks of migraine patients. Headache 14, 139–148 (1974)
Kato, H, Suzuki, T.: Amino acid sequence of bradykinin-potentiating peptide isolated from the venom of Agkistrodon halys blomhoffii. Proc. Jpn. Acad. 46, 176–181 (1970)
Kato, H, Suzuki, T.: Bradykinin-potentiating peptides from the venom of Agkistrodon halys blomhoffii. Isolation of five bradykinin potentiators and the amino acid sequences of two of them, potentiators B and C. Biochemistry 10, 972–980 (1971)
Khairallah, P. A, Page, I.H.: Plasma angiotensinases. Biochem. Med. 1, 1–8 (1967)
Klauser, R.J, Robinson, C.J.G, Erdös, E.G.: Inhibition of human peptidyl dipeptidase (angiotensinI converting enzyme; kininaseII) by serum albumin and its fragments. Hypertension in press (1979)
Koheil, A, Forstner, G.: Isoelectric focusing of carboxypeptidase N. Biochim. Biophys. Acta 524, 156–161 (1978)
Koida, M, Walter, R.: Post-proline cleaving enzyme. Purification of this endopeptidase by affinity chromatography. J. Biol. Chem. 297, 7593–7599 (1976)
Kokubu, T, Kato, I, Nishimura, K, Yoshida, N, Hiwada, K, Ueda, E.: Angiotensin Iconverting enzyme in human urine. Clin. Chim. Acta 89, 375–379 (1978)
Kokubu, T, Ueda, E, Nishimura, K, Yoshida, N.: Angiotensin I converting enzyme activity in pulmonary tissue of fetal and newborn rabbits. Experientia 33, 1137–1138 (1977)
Kreye, V.A.W, Gross, F.: Conversion of angiotensin I to angiotensin II in peripheral vascular beds of the rat. Am. J. Physiol. 220, 1294–1296 (1971)
Krieger, E.M, Salgado, H.C, Assan, C.J, Greene, L.L.J, Ferreira, S.H.: Potential screening test for detection of overactivity of renin-angiotensin system. Lancet 1, 269–271 (1971)
Kroneberg, G, Stoepel, K.: Vergleichende Untersuchungen Über die Kreislaufwirkung von Kallikrein (Padutin), Kallidin, und Bradykinin. Arch. Exp. Pathol. Pharmakol. 245, 284–285 (1963)
Laffan, R.J, Goldberg, M.E, High, J.P, Schaeffer, T.R, Waugh, M.H, Rubin, B.: Antihypertensive activity in rats of SQ 14225, an orally active inhibitor of angiotensin Iconverting enzyme. J. Pharmacol. Exp. Ther. 204, 281–288 (1978)
Lanzillo, J.J, Fanburg, B.L.: Membrane-bound angiotensin-converting enzyme from rat lung. J. Biol. Chem. 249, 2312–2318 (1974)
Lanzillo, J.J, Fanburg, B.L.: Angiotensin I-converting enzyme from guinea pig lung and serum. A comparison of some kinetic and inhibition properties. Biochim. Biophys. Acta 445, 161–168 (1976a)
Lanzillo, J.J, Fanburg, B.L.: The estimation and comparison of molecular weight of angiotensin I converting enzyme by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Biochim. Biophys. Acta 439, 125–132 (1976b)
Lanzillo, J.J, Fanburg, B.L.: Angiotensin I converting enzyme from human plasma. Biochemistry 16, 5491–5495 (1977a)
Lanzillo, J.J, Fanburg, B.L.: Low molecular weight angiotensin I converting enzyme from rat lung. Biochim. Biophys. Acta 491, 339–344 (1977b)
Lee, H.-J, Larue, J.N, Wilson, LB.: Angiotensin-converting enzyme from guinea pig and hog lung. Biochim. Biophys. Acta 250, 549–557 (1971a)
Lee, H.-J, Larue, J.N, Wilson, LB.: Angiotensin-converting enzyme from porcine plasma. Biochim. Biophys. Acta 235, 521–528 (1971b)
Lee, H.-J, Larue, J.N, Wilson, LB.: Dipeptidyl carboxypeptidase from Coryne bacterium equi. Biochim. Biophys. Acta 250, 608–613 (1971c)
Lee, H.-J, Larue, J.N, Wilson, LB.: Human plasma converting enzyme. Arch. Biochem. Biophys. 142, 548–551 (1971d)
LeDuc, L. E, Marshall, G. R, Needleman, P.: Differentiation of bradykinin receptors and of kininases with conformational analogues of bradykinin. Mol. Pharmacol. 14, 413–121 (1978)
Lentz, K.E, Skeggs, L.T, Woods, K.R, Kahn, J.R, Shumway, N.P.: The amino acid composition of hypertensin II and its biochemical relationship to hypertension I. J. Exp. Med. 104, 183–191 (1956)
Leuenberger, P.J, Stalcup, S.A, Mellins, R.B, Greenbaum, L.M, Turino, G.M.: Decrease in angiotensin I conversion by acute hypoxia in dogs. Proc. Soc. Exp. Biol. Med. 158, 586–589 (1978)
Levine, B.W, Talamo, R.C, Kazemi, H.: Action and metabolism of bradykinin in dog lung. J. Appl. Physiol. 34, 821–826 (1973)
Lieberman, J.: Elevation of serum angiotensin-converting-enzyme (ACE) level in sarcoidosis. Am. J. Med. 59, 365–372 (1975)
Lieberman, J.: The specificity and nature of serum-angiotensin-converting enzyme (serum ACE) elevation in sarcoidosis. Ann. N.Y. Acad. Sci. 278, 488–197 (1976)
Lieberman, J, Beutler, E.: Elevation of serum angiotensin-converting enzyme in Gaucher’s disease. N. Engl. J. Med. 294, 1442–1444 (1976)
Lieberman, J, Rea, T.H.: Serum angiotensin-converting enzyme in leprosy and coccidioidomycosis. Ann. Int. Med. 87, 422–425 (1977)
Lukjan, H, Bielawic, M, Kiersnowska, B, Korfel, B, Dowzyk, W.: Kininogenase and kininase activity of the blood in arteriosclerosis. Atherosclerosis 16, 61–66 (1972)
Mäkinen, P.L, Mäkinen, K.K.: Fractionation and properties of aminopeptidase B during purification and storage. Int. J. Pept. Prot. Res. 4, 241–255 (1972)
Mäkinen, K. K, Mäkinen, P.-L.: Evidence of erythrocyte aminopeptidase B. Int. J. Prot. Res. III, 41–47 (1971)
Mäkinen, K.K, Oksala, E.: Evidence on the involvement in inflammation of an enzyme resembling aminopeptidase B. Clin. Chim. Acta 49, 301–309 (1973)
Marinkovic, D. V, Marinkovic, J. N, Robinson, C.J.G, Erdös, E.G.: Purification of two forms of carboxypeptidase B from human pancreas. Biochem. J. 163, 253–260 (1977)
Marks, N.: Exopeptidases of the nervous system. Int. Rev. Neurobiol. 11, 57–97 (1968)
Marks, N.: Conversion and Inactivation of neuropeptides. In: Peptides in neurobiology. Sainer, H. (ed.), pp.221–258. New York: Plenum Press 1977
Marks, N, Pirotta, M.: Breakdown of bradykinin and its analogs by rat brain neutral proteinase. Brain Res. 33, 565–567 (1971)
Massey, T.H, Fessler, D.C.: Substrate binding properties of converting enzyme using a series of p-nitrophenylalanyl derivatives of angiotensin I. Biochemistry 15, 4906–4912 (1976)
Mattioli, L, Zakheim, R.M, Mullis, K, Molteni, A.: Angiotensin-I-converting enzyme activity in idiopathic respiratory distress syndrome of the newborn infant and in experimental alveolar hypoxia in mice. J. Pediatr. 87, 97–101 (1975)
McCaa, R.E, Hall, J.E, McCaa, C.S.: The effects of angiotensin I-converting enzyme inhibitors on arterial blood pressure and urinary sodium excretion. Role of the renal reninangiotensin and kallikrein-kinin systems. Circ. Res. 43, Suppl. 1,I–32–I–39 (1978)
McCormick, J.T, Senior, J.: The effect of the oestrous cycle, pregnancy and reproductive hormones on the kininase activity of rat blood. J. Reprod. Fertil. 30, 381–387 (1972)
McKay, T.J, Plummer, T.H.: By-product analogues for bovine carboxypeptidase B. Biochemistry 17, 401–105 (1978)
McNeill, J. R.: Intestinal vasoconstriction following diuretic-induced volume depletion: role of angiotensin and vasopressin. Can. J. Physiol. Pharmacol. 52, 829–839 (1974)
Merrill, J.E, Peach, M.J, Gilmore, J.P.: Angiotensin I conversion in the kidney and its modulation by sodium balance. Am. J. Physiol. 224, 1104–1108 (1973)
Miller, Jr., E. D, Samuels, A. I, Haber, E, Barger, A. C.: Inhibition of angiotensin conversion and prevention of renal hypertension. Am. J. Physiol. 228, 448 153 (1975)
Mineshita, S, Nagai, Y.: Hydrolysis of bradykinin by stem bromelain. Jpn. J. Pharmacol. 27, 170–172 (1977)
Molteni, A, Zakheim, R. M, Mullis, K. B, Mattioli, L.: The effect of chronic alveolar hypoxia on lung and serum angiotensin I converting enzyme activity. Proc. Soc. Exp. Biol. Med. 147, 263–265 (1974)
Morton, J.J, Semple, P.F, Ledingham, I.McA, Stuart, B, Tehrani, M.A, Garcia, A.R, McGarrity, G.: Effect of angiotensin-converting enzyme inhibitor (SQ 20881) on the plasma concentration of angiotensin I, angiotensin II, and arginine vasopressin in the dog during hemorrhagic shock. Circ. Res. 41, 301–308 (1977)
Möse, J.R, Fischer, G, Briefs, C.: Die Wirkung von Clostridium butyricum (Stamm M 55) auf menschliches Kininogen und ihre Bedeutung fur den Onkolyseprozefi. Zentralbl. Bakteriol. [I] 221, 474–491 (1972a)
Möse, J. R, Fischer, G, Mobascherie, T. B.: Über Bakterienkininasen und deren physiologische Bedeutung 2. Mitteilung: Untersuchungen an Colistammen. Zentralbl. Bakteriol. [I] 219, 465–472 (1972b)
Möse, J. R, Fischer, G, Mobascherie, T. B.: Über Bakterienkininasen und deren physiologische Bedeutung 1. Mitteilung: Untersuchungen an Clostridienstammen. Zentralbl. Bakteriol. [I] 219, 530–541 (1972c)
Movat, H.Z, Steinberg, S.G, Habal, F.M, Ranadive, N.S.: Demonstration of a kinin-generating enzyme in the lysosomes of human polymorphonuclear leukocytes. Lab. Invest. 29, 669–684 (1973a)
Movat, H. Z, Steinberg, S. G, Habal, F. M, Ranadive, N. S.: Kinin-forming and kinin-inactivating enzymes in human neutrophil leukocytes. Agents Actions 3/5, 284–291 (1973b)
Mue, S, Takahashi, M, Ohmi, T, Shibahara, S, Yamauchi, K, Fujimoto, S, Okayama, H, Takishima, T.: Serum angiotensin converting enzyme level in bronchial asthma. Ann. Allergy 40, 51–57 (1978)
Muirhead, E.E, Brooks, B, Arora, K.K.: Prevention of malignant hypertension by the synthetic peptide SQ 20881. Lab. Invest. 30, 129–135 (1974)
Muirhead, E.E, Prewitt, R.L, Brooks, B, Brosius, W.L.: Antihypertensive action of the orally active converting enzyme inhibitor (SQ 14225) in spontaneously hypertensive rats. Circ. Res. 43, Suppl. I, I–53–I–59 (1978)
Murachi, T, Miyake, T.: Action of stem bromelian on bovine bradykininogen II and bradykinin. Physiol. Chem. Phys. 2, 97–104 (1970)
Murthy, V.S, Waldon, T.L, Goldberg, M. E, Vollmer, R.R.: Inhibition of angiotensin converting enzyme by SQ 14225 in conscious rabbits. Eur. J. Pharmacol. 46, 207–212 (1977)
Murthy, V. S, Waldron, T. L, Goldberg, M. E.: Inhibition of angiotensin-converting enzyme by SQ 14225 in anesthetized dogs: hemodynamic and renal vascular effects. Proc. Soc. Exp. Biol. Med. 157, 121–124 (1978a)
Murthy, V.S, Waldron, T.L, Goldberg, M.E.: The mechanism of bradykinin potentiation after inhibition of angiotensin-converting enzyme by SQ 14225 in conscious rabbits. Circ. Res. Suppl. I, I–40–I–45 (1978b)
Nakahara, N.: Plasma hippuryl-l-lysine hydrolase inhibition by low molecular weight substance in lysosomes of skeletal muscle. Biochem. Pharmacol. 21, 2635–2641 (1972)
Nakahara, M.: Plasma hippuryl-l-lysine hydrolase in tourniquet shock. Experientia 29, 999–1000 (1973)
Nakahara, M.: Subunits of human plasma kininase II generated by plasma kallikrein. Biochem. Pharmacol. 27, 1651–1657 (1978)
Nakajima, T, Oshima, G, Yeh, H.S.J, Igic, R.P, Erdös, E.G.: Purification of the angiotensin I converting enzyme of the lung. Biochim. Biophys. Acta 315, 430–438 (1973)
Nasjletti, A, Colina-Chourio, J, McGiff, J. C.: Disappearance of bradykinin in the renal circulation of dogs. Effects of kininase inhibition. Circ. Res. 37, 59–65 (1975)
Needleman, P, Douglas, Jr. J.R, Jakschik, B.B, Blumberg, A.L, Isakson, P.C, Marshall, G.R.: Angiotensin antagonists as pharmacological tools. Fed. Proc. 35, 2488–2493 (1976)
Needleman, P, Johnson, Jr., E. M, Vine, W, Flanigan, E, Marshall, G. R.: Pharmacology of antagonists of angiotensin I and II. Circ. Res. 31, 862–867 (1972)
Needleman, P, Marshall, G. R, Sobel, B. E.: Hormone interactions in the isolated rabbit heart. Synthesis and coronary vasomotor effects of prostaglandins, angiotensin, and bradykinin. Circ. Res. 37, 802–808 (1975)
Ng, K.K.F, Vane, J.R.: Conversion of angiotensin I to angiotensin II. Nature 216, 762–766 (1967)
Ng, K.K.F, Vane, J.R.: Fate of angiotensin I in the circulation. Nature 218, 144–150 (1968)
Nielsen, H. M.: Kinin forming and destroying activities in human bile and mucous membranes of the biliary tract. Br. J. Pharmacol. 37, 172–177 (1969)
Nishimura, K, Hiwada, K, Ueda, E, Kokubu, T.: Affinity chromatography of angiotensin Iconverting enzyme from rabbit lung using hippurylhistidylleucyl-OH. Biochim. Biophys. Acta 445, 158–160 (1976a)
Nishimura, K, Hiwada, K, Ueda, E, Kokubu, T.: Solubilization of angiotensin I converting enzyme from rabbit lung using trypsin treatment. Biochim. Biophys. Acta 452, 144–150 (1976b)
Nishimura, K, Yoshida, N, Hiwada, K, Ueda, E, Kokubu, T.: Purification of angiotensin Iconverting enzyme from human lung. Biochim. Biophys. Acta 483, 398–408 (1977)
Nishimura, K, Yoshida, N, Hiwada, K, Ueda, E, Kokubu, T.: Properties of three different forms of angiotensin I-converting enzyme from human lung. Biochim. Biophys. Acta 522, 119–131 (1978)
Oates, H. F, Stokes, G. S.: Role of extrapulmonary conversion of mediating the systemic pressor activity of angiotensin I. J. Exp. Med. 140, 79–86 (1974)
Odya, C.E, Levin, Y, Erdös, E.G., Robinson, C.J.G.: Soluble dextran complexes of kallikrein, bradykinin and enzyme inhibitors. Biochem. Pharmacol. 27, 173–179 (1978b)
Odya, C.E, Marinkovic, D, Hammon, K.J, Stewart, T.A, Erdös, E.G.: Purification and properties of procarboxypeptidase (angiotensinase C) from human kidney. J. Biol. Chem. 253, 5927–5931 (1978a)
Oh-ishi, S, Sakuma, A, Katori, M.: Kininase activity in equine plasma. Biochem. Pharmacol. 21, 3078–3082 (1972)
Oliveira, E.B, Martins, A.R, Camargo, A.C.M.: Isolation of brain endopeptidases: influence of size and sequence of substrates structurally related to bradykinin. Biochemistry 15, 1961–1974 (1976a)
Oliveira, E.B, Martins, A.R, Camargo, A.C.M.: Rabbit brain thiol-activated endopeptidase. Hydrolysis of bradykinin and kininogen. Gen. Pharmac. 7, 159–161 (1976b)
Olsen, U.B.: Kininase inhibition by glucagon. Acta Endocrinol. 87, 552–556 (1978)
Onabanjo, A.O., Bhabani, A.R, Maegraith, B.G.: The significance of kinin-destroying enzymes activity in Plasmodium knowlesi malarial infection. Br. J. Exp. Pathol. 51, 534–540 (1970)
Ondetti, M.A, Engel, S.L.: Bradykinin analogs containing β-homoamino acids. J. Med. Chem. 18, 761–763 (1975)
Ondetti, M.A, Rubin, B, Cushman, D.W.: Design of specific inhibitors of angiotensinconverting enzyme: New class of orally active antihypertensive agents. Science 196, 441–444 (1977)
Ondetti, M.A, Williams, N.J, Sabo, E.F, Pluscec, J, Weaver, E.R, Kocy, O.: Angiotensinconverting enzyme inhibitors from the venom of Bothrops jararaca. Isolation, elucidation of structure, and synthesis. Biochemistry 10, 4033–4039 (1971)
Oparil, S.: Angiotensin I conversion. In: Renin. Horrobin, D.F. (ed.), Vol.1, pp.56–65. Montreal: Eden Press 1976
Oparil, S, Carone, F.A, Pullman, T.N, Nakamura, S.: Inhibition of proximal tubular hydrolysis and reabsorption of bradykinin by peptides. Am. J. Physiol. 231, 743–748 (1976a)
Oparil, S, Low, J, Koerner, T.J.: Altered angiotensin I conversion in pulmonary disease. Clin. Sci. Mol. Med. 51, 537–543 (1976b)
Oparil, S, Katholi, R.: Angiotensin I conversion. In: Renin. Horrobin, D.F. (ed.), Vol. 2, pp. 72–83. Montreal: Eden Press 1977
Oparil, S, Koerner, T.J, Lindheimer, M.D.: Plasma angiotensin converting enzyme activity in mother and fetus. J. Clin. Endocrinol. Metabol. 46, 434–439 (1978)
Oparil, S, Koerner, T, Tregear, G.W, Barnes, B.A, Haber, E.: Substrate requirements for angiotensin I conversion in vivo and in vitro. Circ. Res. 32, 415–423 (1973)
Oparil, S, Sanders, C.A., Haber, E.: In-vivo and in-vitro conversion of angiotensin I to angiotensin II in dog blood. Circ. Res. 26, 591–599 (1970)
Oparil, S, Tregear, G.W, Koerner, T, Barnes, B.A, Haber, E.: Mechanism of pulmonary conversion of angiotensin I to angiotensin II in the dog. Circ. Res. 29, 682–690 (1971)
Oshima, G, Erdös, E.G.: Inhibition of the angiotensin I converting enzyme of the lung by a peptide fragment of bradykinin. Experientia 30, 733 (1974)
Oshima, G, Geese, A, Erdös, E.G.: Angiotensin I converting enzyme of the kidney cortex. Biochim. Biophys. Acta 350, 26–37 (1974a)
Oshima, G, Kato, J, Erdös, E.G.: Subunits of human plasma carboxypeptidase N (Kininase I; anaphylatoxin inactivator). Biochim. Biophys. Acta 365, 344–348 (1974b)
Oshima, G, Kato, J, Erdös, E. G.: Plasma carboxypeptidase N, subunits and characteristics. Arch. Biochem. Biophys. 110, 132–138 (1975)
Oshima, G, Nagasawa, K.: Some enzymatic properties of peptidyl dipeptide hydrolase (angiotensin I-converting enzyme). J. Biochem. 81, 57–63 (1977)
Oshima, G, Nagasawa, K, Kato, J.: Renal angiotensin I-converting enzyme as a mixture of sialo-and asialo-enzyme, and a rapid purification method. J. Biochem. 80, 477–483 (1976)
Oshima, G, Shimabukuro, H, Nagasawa, K.: Peptide inhibitors of angiotensin converting enzyme in digests of gelatin by bacterial collagenase Biochim. Biophys. Acta 566, 128–137 (1979)
Orlowski, M, Wilk, E.: Concentration of angiotensin converting enzyme and angiotensin degrading enzymes in brain micro vessels. Fed. Proc. 31, 602 (1978)
Overturf, M, Wyatt, S, Boaz, D, Fitz, A.: Angiotensin I (Phe8-His9 ) hydrolase and bradykininase from human lung. Life Sci. 16, 1669–1682 (1975)
Paskhina, T.S, Trapeznikova, S.S, Egopova, T.P, Morozova, N.A.: Effect of bradykininpotentiating snake venom peptides and C-terminal pentapeptide fragment of bradykinin on carboxypeptidase N and kininase activities of human blood serum. Biokhimiya 40, 844–853 (1975)
Persson, A, Wilson, I. B.: A fluorogenic substrate or angiotensin-converting enzyme. Anal. Biochem. 83, 296–303 (1977)
Petakova, M, Simonianova, E, Rybak, M.: Carboxypeptidases N (kininase I) in rat serum lungs, liver and spleen and the inactivation of kinins (Bradykinin). Physiol. Bohemosl. 21, 287–293 (1972)
Pettinger, W.A, Keeton, K, Tanaka, K.: Radioimmunoassay and pharmacokinetics of saralasin in the rat and hypertensive patients. Clin. Pharmacol. Ther. 11, 146–158 (1975)
Piquilloud, Y, Reinharz, A, Roth, M.: Action de l’enzyme de conversion (converting enzyme) sur des substrats synthetiques. Helv. Physiol. Pharmacol. Acta 26, 231–232 (1968)
Piquilloud, Y, Reinharz, A, Roth, M.: Studies on the angiotensin converting enzyme with different substrates. Biochim. Biophys. Acta 206, 136–142 (1970)
Plummer, T.H, Hurwitz, M. Y.: Human plasma carboxypeptidase N. Isolation and characterization. J. Biol. Chem. 253, 3907–3912 (1978)
Poth, M.M., Heath, R.G, Ward, M.: Angiotensin-converting enzyme in human brain. J. Neurochem. 25, 83–85 (1975)
Prado, J.L, Limaos, E. A, Roblero, J, Freitas, J.O, Prado, E.S, Paiva, A.C.M.: Recovery and conversion of kinins in exsanguinated rat preparations. N.S. Arch. Pharmacol. 290, 191–205 (1975)
Re, R, Novelline, R, Escourrou, M.-T, Athanasoulis, C, Bruton, J, Haber, E.: Inhibition of angiotensin-converting enzyme for diagnosis of renal-artery stenosis. N. Engl. J. Med. 298, 582–586 (1978)
Reissmann, S, Paegelov, I, Leisner, H, Arold, H.: Stabilitat verschiedener Bradykininanaloga gegen Kininase II. Experientia 31, 1395–1396 (1975)
Rhoads, R.E, Udenfriend, S.: Substrate specificity of collagen proline hydroxylase: Hydroxylation of a specific proline residue in bradykinin. Arch. Biochem. Biophys. 133, 108–111 (1969)
Rohrbach, M.S.: (Glycine-1-14C) hippuryl-l-Histidyl-l-leucine: A substrate for the radiochemical assay of angiotensin converting enzyme. Anal. Biochem. 84, 272–276 (1978)
Romero, J.C, Mak, S.W, Hoobler, S.W.: Effect of blockade of angiotensin-I converting enzyme on the blood pressure of renal hypertensive rabbits. Cardiovasc. Res. 8, 681–687 (1974)
Roth, M, Weitzman, A.F, Piquilloud, Y.: Converting enzyme content of different tissues of the rat. Experientia 25, 1247 (1969)
Rubin, B, Laffan, R.J, Kotler, D.G, O’Keefe, E.H, Demaio, D.A, Goldberg, M.E.: SQ 14225 (d-3-mercapto-2-methylpropanoyl-l-proline), a novel orally active inhibitor of angiotensin I-converting enzyme. J. Pharmacol. Exp. Ther. 204, 271–280 (1978)
Ryan, J.W, Chung, A, Ammons, C, Carlton, M.L.: A simple radioassay for angiotensinconverting enzyme. Biochem. J. 167, 501–504 (1977)
Ryan, J.W, Day, A.R, Schultz, D.R, Ryan, U.S., Chung, A, Marlborough, D.I, Dorer, F.E.: Localization of angiotensin converting enzyme (kininase II). I. Preparation of antibodyhemeoctapeptide conjugates. Tissue Cell 8, 111–124 (1976a)
Ryan, J.W, Roblero, J, Stewart, J.M.: Inactivation of bradykinin in the pulmonary circulation. Biochem. J. 110, 795–797 (1968)
Ryan, J.W, Roblero, J, Stewart, J.M.: Inactivation of bradykinin in rat lung. Adv. Exp. Med. 8, 263–271 (1970)
Ryan, J.W, Ryan, U.S., Schultz, D.R, Whitaker, C, Chung, A, Dorer, F.E.: Subcellular localization of pulmonary angiotensin-converting enzyme (kininase II), Biochem. J. 146, 497–499 (1975)
Ryan, J.W, Smith, U.: A rapid, simple method for isolating pinocytotic vesicles and plasma membrane of lung. Biochim. Biophys. Acta. 249, 177–180 (1971)
Ryan, U.S., Ryan, J.W, Whitaker, C, Chiu, A.: Localization of angiotensin converting enzyme (kininase II). II. Immunocytochemistry and immunofluorescence. Tissue Cell 8, 125–245 (1976b)
Rybak, M, Blazkova, B, Petakova, M.: Occurrence of aminopeptidases (arylaminopeptidases) in human amniotic fluid and their participation on kinin degradation. H. S. Z. Physiol. Chem. 352, 1611–1616 (1971)
Rybak, M, Mansfeld, V, Grimova, J, Petakova, M.: Effect of carboxypeptidase N, aprotinin and anti-inflammatory drugs of pyrazolidine type on experimental inflammations in rats. Pharmacology 16, 11–16 (1978)
Sampaio, C.A.M., Nunes, S.T, Mazzacoratti, M.D.G.N, Prado, J.L.: Inactivation of kinins by chymotrypsin. Biochem. Pharmacol. 25, 2391–2394 (1976)
Samuels, A.I, Miller, E.D, Fray, J.C.S, Haber, E, Barger, A.C.: Renin-angiotensin antagonists and the regulation of blood pressure. Fed. Proc. 35, 2512–2520 (1976)
Sancho, J, Re, R, Burton, J, Barger, A.C., Haber, E.: The role of the renin-angiotensinaldosterone system in cardiovascular homeostasis in normal human subjects. Circulation 53, 400–495 (1976)
Sander, G. E, Huggins, C G.: Subcellular localization of angiotensin I converting enzyme in rabbit lung. Nature New Biol. 230, 27–29 (1971)
Sander, G.E, West, D.W, Huggins, C.G.: Peptide inhibitors of pulmonary angiotensin I converting enzyme. Biochim. Biophys. Acta 242, 662–667 (1971)
Sander, G.E, West, D.W, Huggins, C.G.: Inhibitors of the pulmonary angiotensinIconverting enzyme. Biochim. Biophys. Acta 289, 392–400 (1972)
Scholz, H.W, Biron, P.: Non-identity between pulmonary bradykininase and convertingenzyme activity. Rev. Can. Biol. 28, 197–200 (1969)
Scicli, A.G, Gandolfi, R, Carretero, O. A.: Site of formation of kinins in the dog nephron. Am. J. Physiol. 234, F36–F40 (1978)
Semple, P. F.:The concentration of angiotensins I and II in blood from the pulmonary artery and left ventricle of man. J. Clin. Endocrinol. Metabol. 44, 915–920 (1977)
Severs, W.B, Summy-Long, J.: The role of angiotensin in thirst. Life Sci. 17, 1513–1526 (1975)
Shikimi, T, Houki, S, Iwata, H.: Pharmacological significances of peptidase and proteinase in the brain Report 3: Substrate specificity and amino acid composition of partially purified enzyme inactivating bradykinin in rat brain. Jpn. J. Pharmacol. 20, 169–170 (1970)
Shikimi, T, Iwata, H.: Pharmacological significances of peptidase and proteinase in the brain-II. Purification and properties of a bradykinin inactivating enzyme from rat brain. Biochem. Pharmacol. 19, 1399–1407 (1970)
Silverstein, E, Friedland, J.: Elevated serum and spleen angiotensin converting enzyme and serum lysozyme in Gaucher’s disease. Clin. Chim. Acta 74, 21–25 (1977)
Silverstein, E, Friedland, J, Lyons, H. A, Gourin, A.: Elevation of angiotensin-converting enzyme in granulomatous lymph nodes and serum in sarcoidosis: Clinical and possible pathogenic significance. Ann. N.Y. Acad. Sci. 278, 498–513 (1976a)
Silverstein, E, Friedland, J, Lyons, H.A, Gourin, A.: Markedly elevated angiotensin converting enzyme in lymph nodes containing non-necrotizing granulomas in sarcoidosis. Proc. Natl. Acad. Sci. USA 73, 2137–2141 (1976b)
Skeggs, L.T, Kahn, J.R, Shumway, N.P.: The preparation and function of the hypertensinconverting enzyme. J. Exp. Med. 103, 295–299 (1956)
Skeggs, L.T, Marsh, W.H, Kahn, J.R, Shumway, N.P.: The existence of two forms of hypertensin. J. Exp. Med. 99, 275–282 (1954)
Smith, R.J, Contrera, J.F.: Cobalt-induced alterations in plasma proteins, proteases and kinin system of the rat. Biochem. Pharmacol. 23, 1095–1103 (1974)
Soffer, R. L.: Angiotensin-converting enzyme and the regulation of vasoactive peptides. Ann. Rev. Biochem. 45, 73–94 (1976)
Soffer, R.L, Reza, R, Caldwell, P.R.B.: Angiotensin-converting enzyme from rabbit pulmonary particles. Proc. Natl. Acad. Sci. USA 71, 1720–1724 (1974)
Stalcup, S.A, Leuenberger, P.J, Lipset, J.S, Turino, G.M, Mellins, R.B.: Decrease in instantaneous pulmonary clearance of bradykinin by acute hypoxia in dogs. Fed. Proc. 37, 292 (1978)
Stanley, P, Biron, P.: Pressor response to angiotensin I during cardio-pulmonary bypass. Experientia 15, 46–47 (1969)
Stevens, R.L, Micalizzi, E.R, Fessler, D.C, Pals, D.T.: Angiotensin I converting enzyme of calf lung. Method of assay and partial purification. Biochemistry 11, 2999–3007 (1972)
Stewart, J.M, Ferreira, S.H, Greene, L.J.: Bradykinin potentiating peptide PCA-Lys-Trp-Ala-Pro. An inhibitor of the pulmonary inactivation of bradykinin and conversion of angiotensin I to II. Biochem. Pharmacol. 20, 1557–1567 (1971)
Streeten, D.H.P, Kerr, L.P, Kerr, C.B, Prior, J.C, Dalakos, T.G.: Hyperbradykininism: A new orthostatic syndrome. Lancet 3, 1048–1053 (1972)
Teger-Nilsson, A.-C.: Degradation of human fibrinopeptides A and B in blood serum in vitro. Acta Chem. Scand. 22, 3171–3182 (1968)
Thurston, H, Laragh, J.H.: Prior receptor occupancy as a determinant of the pressor activity of infused angiotensin II in the rat. Circ. Res. 36, 113–117 (1975)
Thurston, H, Swales, J.D.: Converting enzyme inhibitor and saralasin infusion in rats. Evidence for an additional vasodepressor property of converting enzyme inhibitor. Circ. Res. 42, 588–592 (1978)
Tonzetich, J, Eigen, E, Volpe, A. R, Weiss, S.: Relationship of salivary kininase activity to periodontal status in humans. J. Periodontal. Res. 4, 118–126 (1969)
Trautschold, I.: Assay method in the kinin system. In: Handbook of Experimental Pharmacology. Erdös, E.G. (ed.), Vol. XXV, pp.52–81. Berlin, Heidelberg, New York: Springer 1970
Tsai, B.-S, Khosla, M.C, Peach, M.J, Bumpus, F.M.: Synthesis and evaluation of Des-Asp1-angiotensin I: A precursor for Des-Asp angiotensin II (AIII). J. Med. Chem. 18, 1180–1183 (1975)
Tsai, B.-S, Peach, M.J.: Angiotensin homologs and analogs as inhibitors of rabbit pulmonary angiotensin-converting enzyme. J. Biol. Chem. 252, 4674–4681 (1977)
Tuerker, R. K, Ercan, Z. S.: High degree of conversion of angiotensin I to angiotensin II in the mesenteric circulation of the isolated perfused terminal ileum of the cat. Arch. Int. Physiol. Biochim. 83, 845–853 (1975)
Ueda, E., Akutsu, H, Kokubu, T, Yamamura, Y.: Partial purification and properties of angiotensin I converting enzyme from rabbit plasma. Jpn. Circ. J. 35, 801–806 (1971)
Ueda, E, Kokubu, T, Akutsu, H, Ito, T.: Angiotensin I converting enzyme and kininase. Jpn. Circ. J. 36, 583–586 (1972)
Uszynski, M, Malofiejew, M.: Kininase activity in the human placenta. Biochem. Pharmacol. 20, 3211–3212 (1971)
Vallota, E.H, Muller-Eberhard, H.J.: Formation of C3a and C5a anaphylatoxins in whole human serum after inhibition of the anaphylatoxin inactivator. J. Exp. Med. 137, 1109–1123 (1973)
Vane, J. R.: The release and fate of vaso-active hormones in the circulation. Br. J. Pharmacol. 35, 209–242 (1969)
Vannier, Ch, Louvard, D, Maroux, S, Desnuelle, P.: Structural and topological homology between porcine intestinal and renal brush border aminopeptidase. Biochim. Biophys. Acta 445, 185–199 (1976)
Vennerod, A. M.: Effects of tetraethylthiuram disulphide (disulfiram), diethyldithiocarbamate and ethanol on factors of the kinin system in human blood. Acta Pharmacol. Toxicol. 28, 454–465 (1970)
Wallace, K. B, Bailie, M. D, Hook, J. B.: Angiotensin-converting enzyme in developing lung and kidney. Am. J. Physiol. 234, R141–R145 (1978)
Ward, P.E, Erdös, E.G., Gedney, C.D., Dowben, R.M, Reynolds, R.C.: Isolation of membrane-bound renal enzymes that metabolize kinins and angiotensins. Biochem. J. 157, 642–650 (1976)
Ward, P.E, Erdös, E.G.: Metabolism of kinins and angiotensins in the kidney. In: Kininogenases, kallikrein 4. Haberland, G.L, Rohen, J.W, Suzuku, T. (eds.), pp. 107–110. Stuttgart, New York: Schattauer 1977
Ward, P.E, Gedney, C.D., Dowben, R.M, Erdös, E.G.: Isolation of membrane-bound renal kallikrein and kininase. Biochem. J. 151, 755–758 (1975)
Ward, P.E, Klauser, R.J, Erdös, E.G.: Angiotensin I converting enzyme (peptidyl dipeptidase) in the brush border of human intestinal mucosa. Circulation 58,11–251 (1978a)
Ward, P.E, Schultz, W, Reynolds, R.C, Erdös, E.G.: Metabolism of kinins and angiotensins in the isolated glomerulus and brush border of rat kidney. Lab. Invest. 36, 599–706 (1977)
Ward, P.E, Stewart, T.A, Igic, R.P.: Angiotensin I converting enzyme in retinal blood vessels. Fed. Proc. 37, 658 (1978b)
Weese, W.C, Talamo, R.C, Neyhard, N.L, Kazemi, H.: Presence of a bradykinin-like substances in pulmonary washings. Am. Rev. Resp. Dis. 113, 181–187 (1976)
Wiegershausen, B, Klausch, B, Hennighausen, G, Paegelow, I, Raspe, R.: Content of kininogen and activity of kininase in the amniotic fluid in the various periods of pregnancy. Gynecol. Invest. 1, 234–239 (1970)
Wigger, H.J, Stalcup, S.A.: Distribution and development of angiotensin converting enzyme in the fetal and newborn rabbit. An immunofluorescence study. Lab. Invest. 38, 581–585 (1978)
Williams, G.H.: Angiotensin-dependent hypertension — potential pitfalls in definition. N. Engl. J. Med. 296, 684–685 (1977)
Williams, G.H, Hollenberg, N.K.: Accentuated vascular and endocrine response to SQ 20881 in hypertension. N. Engl. J. Med. 297, 184–188 (1977)
Wright, I.G.: Kinin, kininogen and kininase levels during acute Babesia bovis (=B. argentina) infection of cattle. Br. J. Pharmacol. 61, 567–572 (1977)
Yamashita, M, Oyama, T, Kudo, T.: Effect of the inhibitor of angiotensin I converting enzyme on endocrine function and renal perfusion in haemorrhagic shock. Can. Anaesth. Soc. J. 24, 695–701 (1977)
Yang, H.Y.T, Erdös, E.G.: Second kininase in human blood plasma. Nature 215, 1402–1403 (1967)
Yang, H.Y.T, Erdös, E.G., Chiang, T.S.: New enzymatic route for the inactivation of angiotensin. Nature 218, 1224–1226 (1968)
Yang, H.Y.T, Erdös, E.G., Jenssen, T.A, Levin, Y.: Characterization of an angiotensin I converting enzyme. Fed. Proc. 29, 281 (1970)
Yang, H.Y.T, Erdös, E.G., Jenssen, T.A, Levin, Y.: Characterization of an angiotensin I converting enzyme. Fed. Proc. 29, 281 (1970c)
Yang, H.Y.T, Erdös, E.G., Levin, Y.: A dipeptidyl carboxypeptidase that converts angiotensin I and inactivates bradykinin. Biochim. Biophys. Acta. 214, 374–376 (1970a)
Yang, H.Y.T, Erdös, E.G., Levin, Y.: Characterization of a dipeptide hydrolase (kininase I I: angiotensin I converting enzyme). J. Pharmacol. Exp. Ther. 177, 291–300 (1971)
Yang, H.Y.T, Jenssen, T.A, Erdös, E.G.: Conversion of angiotensin I by a kininase preparation. Clin. Res. 18, 88 (1970b)
Yang, H.Y.T, Neff, N.H.: Distribution and properties of angiotensin converting enzyme of rat brain. J. Neurochem. 19, 2443–2450 (1972)
Yang, H.Y.T, Neff, N.H.: Differential distribution of angiotensin converting enzyme in the anterior and posterior lobe of the rat pituitary. J. Neurochem. 21, 1035–1036 (1973)
Yaron, A, Mlynar, D, Berger, A.: A dipeptidocarboxypeptidase from E. coli. Biochem. Biophys. Res. Commun. 41, 897–902 (1972)
Yokoyama, S, Oobayshi, A, Tanabe, O, Ohata, K, Shibata, Y, Ichishima, E.: Kininase and anti-inflammatory activities of acid carboxypeptidase from penicillium janthinellum. Experientia 31, 1122–1123 (1975)
Zacest, R, Oparil, S, Talamo, R.C.: Studies of plasma bradykinins using radiolabeled substrates. Aust. J. Exp. Biol. Med. Sci. 52, 601–606 (1974)
Arregui, A, Bennett, J. P, Bird, E. D, Yamamura, H. I, Iversen, L. L, Snyder, S. H.: Ann. Neurol. 2, 294 (1977)
Arregui, A, Emson, P.C, Spokes, E.G.: Europ. J. Pharmacol. 52, 121 (1978)
Brunner, H.R, Wauters, J.-P, McKinstry, D, Waeber, B, Turini, G, Gavras, H.: Lancet 1978 II, 704
Bunning, P, Holmquist, B, Riordan, J.F.: Biochem. Biophys. Res. Commun. 83, 1442 (1978)
Fernley, R.T.: Clin. Exp. Pharmacol. Physiol. 4, 267 (1977)
Freeman, R.H, Davis, J.O, Khosla, M.C.: Am. J. Physiol. 234, F130 (1978)
Gavras, H, Faxon, D.R, Berkoben, J, Brunner, H.R, Ryan, T. J.: Circulation 58, 770 (1978)
Hartley, J.L, Soffer, R.L.: Biochem. Biophys. Res. Commun. 83, 1545 (1978)
Hayes, L. W, Goguen, C. A, Ching, S.-F, Slakey, L. L.: Biochem. Biophys. Res. Commun. 82,1147 (1978)
Malfroy, B, Swerts, J.R, Guyon, A, Roques, B.P, Schwartz, J.C.: Nature 276, 523 (1978)
Studdy, P, Bird, R, James, D.G., Sherlock, S.: Lancet 1978 II, 1331
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1979 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Erdös, E.G. (1979). Kininases. In: Erdös, E.G. (eds) Bradykinin, Kallidin and Kallikrein. Handbook of Experimental Pharmacology, vol 25 / 1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-67301-6_12
Download citation
DOI: https://doi.org/10.1007/978-3-642-67301-6_12
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-67303-0
Online ISBN: 978-3-642-67301-6
eBook Packages: Springer Book Archive